Basic information
- Full name
- ALK receptor tyrosine kinase
- Ensembl
- ENSG00000171094.18
- Summary
- This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
- Annotation
- Cancer driver (Oncogene) Druggable target (Tier T1) Protein Kinase Receptor
Protein product
- ENST00000389048.8 Primary ENSP00000373700.3 (3 phosphosites)
- ENST00000618119.4
- ENST00000642122.1
Phosphosites on the primary protein product
Tumor and normal comparison
Signed p-values | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Data type | Meta P | BRCA | CCRCC | COAD | GBM | HNSCC | LSCC | LUAD | OV | PDAC | UCEC |
RNA | -2.9e-18 | - | -0.14 | - | - | -1e-10 | -0.01 | -1.3e-7 | - | -2.3e-4 | - |
protein | -0.071 | - | - | - | - | - | - | -0.071 | - | - | - |
mRNA expression at gene level
Protein expression
Phenotype and mutation association
Manhattan plot summarizing associations of phenotypes and mutations across all cohorts and omics data types
Associations of the protein abundance of ALK with phenotypes and mutations
Signed p-values | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Phenotype | Meta P | BRCA | CCRCC | COAD | GBM | HNSCC | LSCC | LUAD | OV | PDAC | UCEC | |
PROGENy: Androgen | 7.3e-3 | - | - | - | 0.02 | - | - | 0.14 | - | - | - | |
HALLMARK_ANDROGEN_RESPONSE | 7.6e-3 | - | - | - | 0.61 | - | - | 1.1e-3 | - | - | - | |
Clinical: Sex | 7.8e-3 | - | - | - | 0.17 | - | - | 0.017 | - | - | - | |
HALLMARK_OXIDATIVE_PHOSPHORYLATION | 0.018 | - | - | - | 0.079 | - | - | 0.11 | - | - | - | |
HALLMARK_ESTROGEN_RESPONSE_EARLY | 0.033 | - | - | - | 0.22 | - | - | 0.075 | - | - | - | |
Tumor Purity (WGS) | 0.037 | - | - | - | 0.14 | - | - | 0.14 | - | - | - | |
PERT-P100-PRM_DMSO | 0.037 | - | - | - | 0.037 | - | - | - | - | - | - | |
HALLMARK_FATTY_ACID_METABOLISM | 0.085 | - | - | - | 0.19 | - | - | 0.26 | - | - | - | |
Tumor Purity (ABSOLUTE) | 0.096 | - | - | - | 0.21 | - | - | 0.27 | - | - | - | |
PROGENy: MAPK | 0.1 | - | - | - | 0.13 | - | - | 0.44 | - | - | - |
Cis-association
Associations between omics data of ALK
Trans-association
Associations of the protein abundance of ALK and the protein abundance of other genes
Signed p-values | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene | Meta P | BRCA | CCRCC | COAD | GBM | HNSCC | LSCC | LUAD | OV | PDAC | UCEC | |
No matching records found |
Gene set enrichment analysis
Submit genes and the common logarithm of the p-values of their association with to WebGestalt.